IDiyas

For the Inventor, By the Inventor

Biberach, Germany

Adil Duran

USPTO Granted Patents = 15


 

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 175(Granted Patents)


Location History:

  • Rissegg, DE (2007 - 2013)
  • Biberach, DE (2009 - 2013)
  • Rigefield, CT (US) (2013)
  • Biberach an der Riss, DE (2012 - 2017)

Company Filing History:

goldMedal14 out of 1,535 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal2 out of 1,929 
 
Ajinomoto Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9751855 - Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines (2017-09-05),
2. 9499546 - Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines (2016-11-22),
3. 8883805 - Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines (2014-11-11),
4. 8680280 - Process for the manufacturing of CRR inhibitors (2014-03-25),
5. 8420809 - Process for the manufacturing of betamimetics (2013-04-16),
6. 8394791 - Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug (2013-03-12),
7. 8372974 - Regioselective preparation of substituted pyrimidines (2013-02-12),
8. 8334383 - Regioselective preparation of substituted pyrimidines (2012-12-18),
9. 8207335 - Process for making certain compounds having B1 antagonistic activity (2012-06-26),
10. RE43115 - Process for the manufacture of fused piperazin-2-one derivatives (2012-01-16),
11. 7838500 - Crystalline form of 1'-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments (2010-11-23),
12. 7820815 - Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines (2010-10-26),
13. 7626019 - Intermediate compounds for the manufacture of fused piperazin-2-one derivatives (2009-12-01),
14. 7524822 - Crystalline form of 1'-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments (2009-04-28),
15. 7238807 - Process for the manufacture of fused piperazin-2-one derivatives (2007-07-03),

Title: Adil Duran: Innovator in Chiral Chemistry

Introduction

Adil Duran is a prominent inventor based in Biberach, Germany. He has made significant contributions to the field of chiral chemistry, holding a total of 15 patents. His work focuses on the preparation of enantiomerically pure compounds, which are crucial in various pharmaceutical applications.

Latest Patents

Among his latest innovations is a patent for the "Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines." This invention relates to an improved method for synthesizing enantiomerically pure 8-(3-aminopiperidin-1-yl)-xanthines, showcasing his expertise in developing efficient chemical processes.

Career Highlights

Adil Duran has worked with notable companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Ajinomoto Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in chiral compounds.

Collaborations

Throughout his career, Duran has collaborated with esteemed colleagues such as Waldemar F. Pfrengle and Thorsten Pachur. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Adil Duran's innovative work in chiral chemistry and his impressive portfolio of patents highlight his significant impact on the pharmaceutical industry. His contributions continue to advance the field and improve the synthesis of important compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…